MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ijantimicag.2026.108029

Медицинская библиотека · International journal of antimicrobial agents · 2026

OmpK36 Alterations Are Associated with Reduced Imipenem/Relebactam Susceptibility in KPC-2-Producing Klebsiella pneumoniae, with Dose-Dependent Restoration at Higher Relebactam Concentrations.

Baek Jin Yang, Cho Yun Young, Yang Jinyoung, Huh Kyungmin, Cho Sun Young, Kang Cheol-In, Chung Doo Ryeon, Peck Kyong Ran, Huh Hee Jae, Kim Tae Yeul, Ko Jae-Hoon

СтатьяПеревод в очереди

Аннотация

INTRODUCTION

Resistance to novel β-lactam/β-lactamase inhibitor (BL/BLI) combinations among KPC-2-producing Klebsiella pneumoniae poses a therapeutic challenge. Although resistance driven by KPC-2 mutations following drug exposure has been described, increased MICs are frequently observed in the absence of KPC mutations.

METHODS

We performed whole-genome sequencing and quantitative transcript analysis of 13 KPC-2-producing K. pneumoniae isolates that were non-susceptible to novel BL/BLI combinations, primarily imipenem/relebactam, despite being collected prior to their clinical introduction.

RESULTS

The 13 isolates were non-susceptible to ceftazidime/avibactam (7.7%), imipenem/relebactam (92.3%), or meropenem/vaborbactam (15.4%), and demonstrated dose-dependent reductions in BL MICs with increasing BLI concentrations. Whole-genome sequencing identified truncating ompK36 mutations in 8 isolates (61.5%) and non-truncating variants, including missense substitutions and/or in-frame indels, in 3 isolates (23.1%). Transcript analysis showed ≥2-fold reduced ompK36 expression in 6 isolates with ompK36 mutations, including four with marked (≥3-fold) and one with profound (≥10-fold) suppression. The only isolate that remained resistant to imipenem/relebactam despite a four-fold increase in relebactam concentration exhibited profound suppression of ompK35 and ompK36 and harbored concurrent truncating mutations in both genes. In contrast, blaKPC-2 expression varied by <2-fold across all isolates.

CONCLUSIONS

Loss or reduced expression of ompK36 was associated with reduced imipenem/relebactam susceptibility and dose-dependent responses to increasing relebactam concentrations, without evidence of β-lactamase overexpression or KPC-2 mutation.

Для цитирования: Baek Jin Yang, Cho Yun Young, Yang Jinyoung, Huh Kyungmin, Cho Sun Young, Kang Cheol-In, Chung Doo Ryeon, Peck Kyong Ran, Huh Hee Jae, Kim Tae Yeul, Ko Jae-Hoon. OmpK36 Alterations Are Associated with Reduced Imipenem/Relebactam Susceptibility in KPC-2-Producing Klebsiella pneumoniae, with Dose-Dependent Restoration at Higher Relebactam Concentrations.. International journal of antimicrobial agents. 2026. DOI: 10.1016/j.ijantimicag.2026.108029.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.